Vemico Ltd

veMico is a UK-based biotechnology company focused on the development of science-led, clinically validated oral solutions that target gut and immune health through host-centred mechanisms. Our approach prioritises the integrity and function of the gut barrier, modulation of host responses, and the use of postbiotics and selective bioactives—rather than relying on microbiota alteration alone. With over 25 years of combined expertise in microbiology, gut–host interaction, and translational research, we collaborate with academic and industry partners to advance targeted interventions for gut health and beyond.